Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Liabilities-and-Stockholders-Equity" stands at 0.7333 Trillion Japanese Yens as of 06/30/2025, the lowest value since 12/31/2016.
As of the end of Sumitomo Dainippon Pharma Co Ltd's first quarter, the item "Liabilities and Stockholders Equity" stands at 0.7333 Trillion JPY. This represents a decrease of -1.25 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -15.61 percent compared to the value the year prior.
The 1 year change in percent is -15.61.
The 3 year change in percent is -48.46.
The 5 year change in percent is -40.68.
The 10 year change in percent is 0.8271.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Liabilities and Stockholders Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Liabilities and Stockholders Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Liabilities and Stockholders Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Liabilities and Stockholders Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Liabilities and Stockholders Equity | 280,205,508,085.11 |